These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 23134618)

  • 41. DTome: a web-based tool for drug-target interactome construction.
    Sun J; Wu Y; Xu H; Zhao Z
    BMC Bioinformatics; 2012 Jun; 13 Suppl 9(Suppl 9):S7. PubMed ID: 22901092
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Validation of a network-based strategy for the optimization of combinatorial target selection in breast cancer therapy: siRNA knockdown of network targets in MDA-MB-231 cells as an in vitro model for inhibition of tumor development.
    Tilli TM; Carels N; Tuszynski JA; Pasdar M
    Oncotarget; 2016 Sep; 7(39):63189-63203. PubMed ID: 27527857
    [TBL] [Abstract][Full Text] [Related]  

  • 43. HPD: an online integrated human pathway database enabling systems biology studies.
    Chowbina SR; Wu X; Zhang F; Li PM; Pandey R; Kasamsetty HN; Chen JY
    BMC Bioinformatics; 2009 Oct; 10 Suppl 11(Suppl 11):S5. PubMed ID: 19811689
    [TBL] [Abstract][Full Text] [Related]  

  • 44. PCDq: human protein complex database with quality index which summarizes different levels of evidences of protein complexes predicted from h-invitational protein-protein interactions integrative dataset.
    Kikugawa S; Nishikata K; Murakami K; Sato Y; Suzuki M; Altaf-Ul-Amin M; Kanaya S; Imanishi T
    BMC Syst Biol; 2012; 6 Suppl 2(Suppl 2):S7. PubMed ID: 23282181
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prioritization of candidate cancer drugs based on a drug functional similarity network constructed by integrating pathway activities and drug activities.
    Di J; Zheng B; Kong Q; Jiang Y; Liu S; Yang Y; Han X; Sheng Y; Zhang Y; Cheng L; Han J
    Mol Oncol; 2019 Oct; 13(10):2259-2277. PubMed ID: 31408580
    [TBL] [Abstract][Full Text] [Related]  

  • 46. MSD-MAP: A Network-Based Systems Biology Platform for Predicting Disease-Metabolite Links.
    Wathieu H; Issa NT; Mohandoss M; Byers SW; Dakshanamurthy S
    Comb Chem High Throughput Screen; 2017; 20(3):193-207. PubMed ID: 28024464
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Integrative Bioinformatics Analysis Reveals Potential Target Genes and TNFα Signaling Inhibition by Brazilin in Metastatic Breast Cancer Cells.
    Hermawan A; Putri H
    Asian Pac J Cancer Prev; 2020 Sep; 21(9):2751-2762. PubMed ID: 32986377
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Application of pharmacometrics and quantitative systems pharmacology to cancer therapy: The example of luminal a breast cancer.
    Fleisher B; Brown AN; Ait-Oudhia S
    Pharmacol Res; 2017 Oct; 124():20-33. PubMed ID: 28735000
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Extended Multitarget Pharmacology of Anticancer Drugs.
    Shi D; Khan F; Abagyan R
    J Chem Inf Model; 2019 Jun; 59(6):3006-3017. PubMed ID: 31025863
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Network-based prediction and knowledge mining of disease genes.
    Carson MB; Lu H
    BMC Med Genomics; 2015; 8 Suppl 2(Suppl 2):S9. PubMed ID: 26043920
    [TBL] [Abstract][Full Text] [Related]  

  • 51. PID: the Pathway Interaction Database.
    Schaefer CF; Anthony K; Krupa S; Buchoff J; Day M; Hannay T; Buetow KH
    Nucleic Acids Res; 2009 Jan; 37(Database issue):D674-9. PubMed ID: 18832364
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Investigating the therapeutic potential and mechanism of curcumin in breast cancer based on RNA sequencing and bioinformatics analysis.
    Wang R; Li J; Zhao Y; Li Y; Yin L
    Breast Cancer; 2018 Mar; 25(2):206-212. PubMed ID: 29139094
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Identification of candidate small-molecule therapeutics to cancer by gene-signature perturbation in connectivity mapping.
    McArt DG; Zhang SD
    PLoS One; 2011 Jan; 6(1):e16382. PubMed ID: 21305029
    [TBL] [Abstract][Full Text] [Related]  

  • 54. DMAP: a connectivity map database to enable identification of novel drug repositioning candidates.
    Huang H; Nguyen T; Ibrahim S; Shantharam S; Yue Z; Chen JY
    BMC Bioinformatics; 2015; 16 Suppl 13(Suppl 13):S4. PubMed ID: 26423722
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Internet Databases of the Properties, Enzymatic Reactions, and Metabolism of Small Molecules-Search Options and Applications in Food Science.
    Minkiewicz P; Darewicz M; Iwaniak A; Bucholska J; Starowicz P; Czyrko E
    Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27929431
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Identifying differentially expressed genes and screening small molecule drugs for lapatinib-resistance of breast cancer by a bioinformatics strategy.
    Zhuo WL; Zhang L; Xie QC; Zhu B; Chen ZT
    Asian Pac J Cancer Prev; 2014; 15(24):10847-53. PubMed ID: 25605188
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mining and evaluation of molecular relationships in literature.
    Senger C; Grüning BA; Erxleben A; Döring K; Patel H; Flemming S; Merfort I; Günther S
    Bioinformatics; 2012 Mar; 28(5):709-14. PubMed ID: 22247277
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A Steiner tree-based method for biomarker discovery and classification in breast cancer metastasis.
    Jahid MJ; Ruan J
    BMC Genomics; 2012; 13 Suppl 6(Suppl 6):S8. PubMed ID: 23134806
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Computational Drug Discovery in Chemotherapy-induced Alopecia via Text Mining and Biomedical Databases.
    Zhang N; Xu W; Wang S; Qiao Y; Zhang X
    Clin Ther; 2019 May; 41(5):972-980.e8. PubMed ID: 31030996
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Network pharmacology evaluation of the active ingredients and potential targets of XiaoLuoWan for application to uterine fibroids.
    Yu Y; Yang F; Liu H
    Biosci Rep; 2020 Dec; 40(12):. PubMed ID: 33196098
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.